Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Self-Injections Market Growth in 2025?

The market for self-injections has seen significant growth in the past few years. It is projected to expand from $9.69 billion in 2024 to $10.3 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 6.3%. The escalation in the preceding period can be credited to factors such as the increase in chronic illnesses, enhanced patient involvement, regulatory backing, a leaning towards home healthcare, and its cost-effective nature.

What Is the Forecast for the Self-Injections Market Size Through 2029?

The market size of self-injections is predicted to witness a significant increase in the coming years, reaching a value of $14.13 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. The projected surge during this period is attributed to factors like the effects of the pandemic and remote treatment, the introduction to emerging markets, patient-focused healthcare, benefits in drug delivery, and the emergence of personalized medicine. Noteworthy trends for this forecast period include the incorporation of smart technology, an increase in the use of biologics, the miniaturization and prevalence of wearable devices, improved safety features, and the increasing use of autoinjectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp

What are the Key Market Players in Self-Injections Market and How They’re Evolving?

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

What Are the Primary Growth Drivers in the Self-Injections Market?

The rise in diabetes patients is predicted to fuel the expansion of the self-injections market in the future. Diabetes is a condition in which the pancreas, the organ that generates insulin in the human body, produces an insufficient amount of insulin. This can lead to blood sugar breakdown, causing serious health problems such as heart disorders, loss of vision, and kidney diseases. Using self-injections, diabetics can inject insulin and other drugs to ensure appropriate blood sugar levels are maintained and avoid elevated blood sugar levels without needing a healthcare professional. For example, the IDF Diabetes Atlas, a global resource from Belgium offering exhaustive data and insights on global diabetes prevalence, treatment, and care, projected in March 2022 that the number of diabetics worldwide would rise from 643 million in 2030 to 783 million by 2045, with an additional 140 million cases. Presently, 537 million adults are living with diabetes, with the majority (over 75%) in lower and middle-income countries. Consequently, the surging number of diabetic patients is spearheading the expansion of the self-injections market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8235&type=smp

What Are the Leading Segments in the Global Self-Injections Industry?

The self-injections market covered in this report is segmented –

1) By Type: Devices, Formulations

2) By Route Of Administration: Skin, Circulatory Or Musculoskeletal, Organs, Central Nervous System

3) By Dosage: Single Dose, Multi Dose

4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications

5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies

Subsegments:

1) By Devices: Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors

2) By Formulations: Biologics, Vaccines, Small Molecules, Combination Products

What Are the Key Market Trends in the Self-Injections Industry?

Leading corporations in the self-injections market are innovating new solutions for insulin injections to achieve an advantageous position in the industry. In this context, Terumo Corporation, a renowned medical device firm based in Japan, unveiled FineGlide in September 2022. This is a Sterile Pen Needle engineered for those who need regular insulin injections or other types of self-administered medication. Designed to work with the most frequently used pen devices in India, FineGlide is aimed towards patient comfort, with the intent to improve adherence to prescribed medication. It features a 3-bevel ultra-sharp needle encased in a high-grade silicon surface, prioritizing ease and comfort for patients. Furthermore, the use of Thin Wall Technology in its design enhances flow rate while also reducing the force required for injections.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

What Is the Regional Outlook for the Self-Injections Market?

North America was the largest region in the self-injections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8235

This Report Delivers Insight On:

1. How big is the self-injections market, and how is it changing globally?

2. Who are the major companies in the self-injections market, and how are they performing?

3. What are the key opportunities and risks in the self-injections market right now?

4. Which products or customer segments are growing the most in the self-injections market?

5. What factors are helping or slowing down the growth of the self-injections market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model